Although rapamycin has been used in several in vitro models of infection with promising effects on intracellular bacterial clearance 34–38, it was recently reported that rapamycin at micromolar (μM) concentrations directly binds and activates TRPML1 22. Here, MCOLN1 is linked to infection.